Skip to content

Efficacy of a participation-oriented outpatient neurorehabilitation program in patients with chronic acquired brain injury

Efficacy of a participation-oriented outpatient neurorehabilitation program in patients with chronic acquired brain injury - TEAM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009602
Enrollment
50
Registered
2015-11-19
Start date
2012-12-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I61 I63 S06

Interventions

Group 1: Treatment for 4 weeks with an intensive interdisciplinary outpatient neurorehabilitation program with 4 hours of therapy per day (monday - friday), called TEAM intervention. This intervention

Sponsors

Neurologische KlinikKlinikum der Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Stroke or traumatic brain injury at least 6 months prior to enrollment, Discharge from inpatient neurorehabilitation at least 3 months prior to enrollment, Daily commute to the Burgau treatment site feasible, Capability to endure at least 6 hours of daily therapy, Life expectancy of at least 1 year, Informed consent by patient or legal representative, Age: 18-85 years

Exclusion criteria

Exclusion criteria: Lack of participation impairment, Insufficient German language skills, Unwillingness of health care plan to cover the associated treatment costs

Design outcomes

Primary

MeasureTime frame
Achieving an individually defined therapeutic goal, assessed by means of the Goal Attainment Scale (GAS) at the start of the study (t1), after 1 month (t2), after 3 months (t3), after 4 months (t4), after 6 months (t5), and after 12 months (t6; all time points given in relation to the baseline t1 measurement)

Secondary

MeasureTime frame
Improvement of the independence in the activities of daily living (measured by FIM), improvement of the quality of life (measured by EuroQOL, SF-36), improvement of life participation (measured by WHODAS II), reduction of caregiver strain (measured by mCSI), each at the start of the study (t1), after 1 month (t2), after 3 months (t3), after 4 months (t4), after 6 months (t5), and after 12 months (t6; all time points given in relation to the baseline t1 measurement)

Countries

Germany

Contacts

Public ContactLuzia Fischer

Therapiezentrum Burgau

l.fischer@therapiezentrum-burgau.de+498222404404

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026